Efficacy and Tolerability of First-Line Anti-eGFR and Anti-VEGF Therapy in Elderly Patients with Ras-Wild Metastatic Colon Cancer

Introduction: Adding targeted agents to chemotherapy for metastatic colorectal cancer increases survival. There have been no clinical trials in older populations comparing the efficacy of the targeted agents. We aimed to compare the efficacy and tolerability of anti-epidermal growth factor receptor...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Ender Doğan, Sedat Tarık Fırat, Murat Eser, Oktay Bozkurt, Mevlüde İnanç, Metin Özkan
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	İstanbul Training and Research Hospital 2024-08-01
Edice:	İstanbul Medical Journal
Témata:	colon cancer vascular endotelial growth factor epidermal growth factor elderly
On-line přístup:	https://istanbulmedicaljournal.org/articles/efficacy-and-tolerability-of-first-line-anti-egfr-and-anti-vegf-therapy-in-elderly-patients-with-ras-wild-metastatic-colon-cancer/doi/imj.galenos.2024.78278
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!